Canadian Health Industry News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Canadian Health Industry News.

Press releases published on April 1, 2026

Apr. 1, 2026

7,000 US Workers Will Get Hurt Today. A New Book Says There is a Better Way to Care for Them

Indeterminate EIN Presswire

Apr. 1, 2026

New Data Reveals the Power of Promotional Products: 72 Research-Based Statistics

Indeterminate EIN Presswire

Apr. 1, 2026

SleepScriptMD Offers Fast, Flexible Sleep Care with Same-Day Prescription Approval Across the U.S.

Indeterminate EIN Presswire

Apr. 1, 2026

Physician Collaborators Offers Affordable Collaboration Across Primary Care, Psychiatry, Urgent Care, & Med Spa Services

Indeterminate EIN Presswire

Apr. 1, 2026

Times Square Billboards Highlight Environmental Risks Linked to Parkinson’s

Indeterminate EIN Presswire

Apr. 1, 2026

XORTX Confirms Effective Date of Share Consolidation

Indeterminate GlobeNewswire

Apr. 1, 2026

DIAGNOS Successfully Completes the Renewal of US-FDA Medical Device Establishment Registration

Indeterminate GlobeNewswire

Apr. 1, 2026

DIAGNOS complète avec succès le processus de renouvellement d’enregistrement d’établissement auprès de la US-FDA

Indeterminate GlobeNewswire

Apr. 1, 2026

Extendicare Acquires CBI Home Health

Indeterminate GlobeNewswire

Apr. 1, 2026

NurExone Receives First Place in Healthcare at BOLD Awards VII and Engages Investor Brand Network to Support Awareness Strategy

Indeterminate GlobeNewswire

Apr. 1, 2026

Cannabix Technologies Announces Delivery of Marijuana Breath Test (MBT) to Virginia based Industrial Manufacturing Client

Indeterminate GlobeNewswire

Apr. 1, 2026

FeraMAX is Canada's Top-Ranked Iron Supplement for 11 Consecutive Years

Indeterminate GlobeNewswire

Apr. 1, 2026

FeraMAX est le supplemént de fer le plus recommandé au Canada depuis 11 années consécutives

Indeterminate GlobeNewswire

Apr. 1, 2026

Incision-Free, MRI-Guided Prostate Treatment with Profound’s TULSA-PRO® to be Featured in Multiple Presentations at the Upcoming 2026 Society of Interventional Radiology Scientific Meeting

Indeterminate GlobeNewswire

Apr. 1, 2026

Quantum BioPharma Submits Investigational New Drug (IND) Application to United States Food and Drug Administration (FDA) for Lucid-MS Phase Two Clinical Trial in Multiple Sclerosis

Indeterminate GlobeNewswire

Apr. 1, 2026

Avicanna Reports Full Year 2025 Audited Financial Statements

Indeterminate GlobeNewswire